scispace - formally typeset
M

Marco Spada

Researcher at University of Turin

Publications -  102
Citations -  2712

Marco Spada is an academic researcher from University of Turin. The author has contributed to research in topics: Fabry disease & Tetrahydrobiopterin. The author has an hindex of 21, co-authored 102 publications receiving 2227 citations. Previous affiliations of Marco Spada include Boston Children's Hospital & ISMETT.

Papers
More filters
Journal ArticleDOI

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

TL;DR: The results suggest that the later-onset phenotype of Fabry disease is underdiagnosed among males with cardiac, cerebrovascular, and/or renal disease and raises ethical issues related to when screening should be performed--in the neonatal period or at early maturity, perhaps in conjunction with screening for other treatable adult-ONSet disorders.
Journal ArticleDOI

Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.

TL;DR: Almost all the patients, especially those with early onset, had some degree of neurologic impairment and mental retardation, and many patients were at less than 2 SD for weight or height or both, in contrast, the neurologic and mental status of the late-onset patients was frequently normal, and their weight and height were more often within normal limits.
Journal ArticleDOI

Clinical outcome and long-term management of 17 patients with propionic acidaemia.

TL;DR: The prognosis for patients with propionic acidaemia appeared to be satisfactory in terms of survival and outcome characteristics such as neurological and mental development, and the authors feel that the prognosis and quality of life of these patients might be improved with liver transplantation or possibly somatic gene therapy in the future.